• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home StudyGraphics

#VisualAbstract: Insulin Efsitora is Noninferior to Insulin Glargine in Type 2 Diabetes without Previous Insulin Therapy

byAstrid BradshawandAlisha Yi
July 16, 2025
in StudyGraphics
Reading Time: 1 min read
0
Share on FacebookShare on Twitter

Click here to read this study in NEJM. 

©2025 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

RELATED REPORTS

Aerobic-resistance training and high-intensity interval training may improve metabolic and functional outcomes in adults with type 2 diabetes

2 Minute Medicine Rewind December 15, 2025

Dulaglutide, semaglutide, and tirzepatide exhibit comparable gastrointestinal adverse event risk

Tags: insulininsulin efsitorainsulin glargineT2Dtype 2 diabetesType 2 Diabetes Mellitus
Previous Post

Thrombolysis-to-puncture time greater than 70 minutes decreases odds of successful thrombectomy

Next Post

New-generation antiseizure medications are better tolerated for patients with epilepsy

RelatedReports

Pediatric DKA associated with recent acute care visits
Chronic Disease

Aerobic-resistance training and high-intensity interval training may improve metabolic and functional outcomes in adults with type 2 diabetes

January 13, 2026
Letrozole (Femara) boosts fertility of women with Polycystic Ovarian Syndrome
Weekly Rewinds

2 Minute Medicine Rewind December 15, 2025

December 15, 2025
Quick Take: The clinical effectiveness of sertraline in primary care and the role of depression severity and duration (PANDA): a pragmatic, double-blind, placebo-controlled randomized trial
Chronic Disease

Dulaglutide, semaglutide, and tirzepatide exhibit comparable gastrointestinal adverse event risk

November 23, 2025
Chronic Disease

Risk of major adverse cardiovascular events is lowest with glucagon-like-peptide-1 receptor agonists among patients with type 2 diabetes being treated with antihyperglycemics

January 13, 2026
Next Post

New-generation antiseizure medications are better tolerated for patients with epilepsy

Quick Take: Risk of rhabdomyolysis with donepezil compared with rivastigmine or galantamine

Risk of dementia increased with gabapentin prescription in back pain patients

Quick Take: Effect of Pregabalin on Radiotherapy-Related Neuropathic Pain in Patients With Head and Neck Cancer: A Randomized Controlled Trial

MLC901 may be effective in treatment of post-concussion symptoms in phase III study

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Smartphone-based digital ruler achieved high diagnostic performance for strabismus screening
  • Safety and efficacy profile of first-in-class oral p53 reactivator rezatapopt
  • Ex vivo gene therapy for cystinosis had acceptable safety and improved disease biomarkers
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.